11/16/2022
RedChip Logo

RedChip Companies

Weekly Newsletter
 

Unicycive Completes Enrollment of Pivotal Bioequivalence Study for RENAZORB, an Investigational Treatment for Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis

Unicycive Therapeutics (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, completed for its pivotal RENAZORB bioequivalence (BE) study. The Company expects to report top-line data from this pivotal study by year-end 2022.

For more information, visit www.unicycive.com

 
See More Info
 
 
 

Save Foods Kicks off the 2022-2023 Northern Hemisphere Citrus Season

Save Foods (Nasdaq: SVFD), an agri-food tech company specializing in eco-crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, has kicked off the Northern Hemisphere citrus season and anticipates that approximately 400,000 tons of citrus fruit will be treated with the Company’s solution this season at new and existing packing houses across Turkey, Egypt, Mexico, the US, and Israel. The Northern Hemisphere citrus season runs from November through April.

 
Learn More
   

Genetic Technologies’ geneType for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention

Genetic Technologies (Nasdaq: GENE), a global leader in guideline driven genomics-based tests in health, wellness and serious disease, announced the publication of a validation study evaluating the performance of the geneType ovarian cancer test. This 10 year prospective cohort study utilizes data from more than 190,000 women and has been published in the prestigious European Journal of Cancer Prevention.

 
Learn More
 

Siyata Mobile Announces Third Quarter 2022 Financial Results

Siyata Mobile (Nasdaq: SYTA), a global vendor of Push-to-Talk over Cellular (PoC) devices and cellular signal booster systems, reported Q3 revenue up 111% to $2.6 million driven by increasing purchase orders for the Company’s game-changing rugged SD7 push-to-talk device.

 
Learn More
 

Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights

Lantern Pharma (Nasdaq: LTRN), announced Q3 operational highlights and financial results. The Company is now advancing two drug-candidates in the Phase 2 clinical stage, and expects to launch two additional drug-candidates into first in human clinical trials in early 2023.

 
Learn More
 

 
 

Upcoming Events

22
November
2022
NASDAQ: UNCY - Unicycive Therapeutics Inc.
4:15pm Eastern
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia.
 
Sign Up
 
1
December
2022
NYSE American: CANF - Can-Fite BioPharma Ltd.
11:00am Eastern
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Psoriasis, and liver diseases including advanced liver cancer and NASH.
 
Sign Up
 
1
December
2022
OTCQB: ILAL - International Land Alliance
4:15pm Eastern
International Land Alliance (ILAL) is a developer of residential communities in Northern Baja California with projects are targeted at buyers and investors of primary, vacation, and/or retirement homes.
 
Sign Up
 
6
December
2022
NASDAQ: GENE - Genetic Technologies Limited
4:15pm Eastern
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class.
 
Sign Up
 
7
December
2022
NYSE American - DSS
11:00am Eastern
DSS Inc. is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, securitized digital assets, securities trading and fund management, and banking, lending, and finance.
 
Sign Up
 
8
December
2022
NASDAQ: ASPI - ASP Isotopess
4:15pm Eastern
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries.
 
Sign Up
 
 
 

Archive Events

10
November
2022
NASDAQ: IINN - Inspira Technologies
Meeting Duration 43 minutes
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure.
 
Watch Replay
 
10
November
2022
NASDAQ: DGLY- Digital Ally Inc.
Meeting Duration 45 minutes
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets.
 
Watch Replay
 
9
November
2022
NASDAQ: HPCO - Hempacco Co., Inc.
Meeting Duration 30 minutes
Hempacco Co, Inc. is Disrupting Tobacco™ and its nearly $1 trillion industry by manufacturing and selling herb and hemp smokables from San Diego, California.
 
Watch Replay
 
7
November
2022
NASDAQ: SVFD - Save Foods
Meeting Duration 45 minutes
Save Foods Inc and its Israeli subsidiary Save Foods Ltd are innovative, dynamic companies dedicated to delivering integrated eco-friendly solutions for improved safety, freshness and quality, every step of the way from field to fork.
 
Watch Replay
 
3
November
2022
NASDAQ: RVSN - Rail Vision
Meeting Duration 31 minutes
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. With the Company’s unique cognitive sensor fusion technology, based on advanced electrooptic sensors, artificial intelligence and deep learning, Rail Vision systems detect objects on and along the tracks from a distance of up to two kilometers – in real time – as well as in all weather and light conditions.
 
Watch Replay
 
 
 

Lesson of the Week

Learn when to sell in this week's lesson.

 
Learn More
 
 
 
All Videos
Full Episodes
 

RedChip TV

This Week on RedChip TV: Three Small Cap Medical Companies Flying Under the Radar

Investors: Participate in Israel’s Burgeoning Technology Sector with Medigus

BioVie: People-Centered Science for Alzheimer's, Parkinson's, and Ascites

ASP Isotopes: Creating a Brighter, Cleaner Future for Isotope Production

International Land Alliance: Developing Properties in Northern Baja California, Mexico

Save Foods: Innovative Solutions to Reduce Food Waste and Ensure Food Safety

Bragg Gaming: Creating Cutting-Edge B2B iGaming Technolgy and Casino Content

 
 

MidSouth Week in Review

For the week the S&P rose 6.0%.

 
Learn More
 
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
© 2022 RedChip , All rights reserved